IDEAYA Biosciences, Inc., a precision medicine oncology company, announced on June 27, 2025, that its Board of Directors' Compensation Committee has granted non-qualified stock options for a total of 95,600 shares to a newly hired employee. These options, issued under the IDEAYA Biosciences, Inc. 2023 Employment Inducement Incentive Award Plan, were given as an inducement for joining the company. The stock options have an exercise price of $22.29 per share, corresponding to the closing price on the Nasdaq Global Select Market on the grant date. With a 10-year term, the options vest over four years, starting with 25% after the first year and the remaining 75% in equal monthly installments over the subsequent three years, contingent on the employee's continued service to IDEAYA.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。